What is the recommended CT (Computed Tomography) protocol for staging cancer?

CT Protocol for Cancer Staging

For cancer staging, perform contrast-enhanced CT of the chest, abdomen, and pelvis using intravenous contrast with thin-slice (3-5 mm) acquisition in a single portal venous phase, or employ a multiphase liver protocol (arterial, portal venous, and delayed phases) when optimal liver metastasis detection is critical. 1

Core Technical Parameters

Contrast Administration

• Administer 90-120 mL of iodinated contrast at 3-4 mL/second injection rate with a 30-second delay for optimal tumor-to-parenchyma differentiation 1
• Use saline flush after contrast injection to improve contrast utilization and reduce brachiocephalic vein artifacts 1
• Standard iodine concentration (300-350 mg I/mL) is appropriate; moderate concentrations (300 mg I/mL) may be more effective for hypervascular lesions when administered rapidly 2

Slice Thickness and Reconstruction

• Acquire thin sections of 3-5 mm (or 1-1.25 mm for lung cancer) with overlapping reconstruction every 0.6-1 mm to create near-isotropic datasets 1
• Reconstruct 1.5 mm thick sagittal and coronal reformats for peripheral tumors; 2-4 mm sections perpendicular to tumor interface for mediastinal/chest wall involvement 1
• Thin slices substantially reduce partial volume averaging and improve fine structure visualization 1

Anatomic Coverage by Cancer Type

Lung Cancer

• CT chest with IV contrast is mandatory (Grade 1B recommendation) 1
• Extend coverage to include liver and adrenal glands if PET scan unavailable 1
• Scan in caudocranial direction to reduce breathing artifacts 1
• Patient should cough immediately before scan to clear tracheobronchial mucus 1

Colorectal Cancer

• Single-phase portal venous CT of chest, abdomen, and pelvis with IV contrast for distant metastasis detection 1
• Alternative: Multiphase liver protocol (arterial, portal venous, delayed) paired with single-phase chest and pelvis imaging 1
• CT accuracy for rectal cancer locoregional staging is 50-70% overall, improving to 86% with thin-section multidetector CT and multiplanar reformats 1

Ovarian Cancer

• Contrast-enhanced CT of abdomen and pelvis with oral contrast, including chest when indicated 1
• IV contrast is preferable for detection and characterization of tumor deposits 1

Gastric Cancer

• Contrast-enhanced thoracoabdominal multidetector CT with ≥16 rows using dedicated protocol optimized for serosal invasion and minimal peritoneal disease 1
• Images must be analyzed by experienced reader 1

Multiphase Liver Protocols

When to Use Multiphase Imaging

• Employ multiphase liver acquisition (arterial, portal venous, delayed phases) to improve diagnostic characterization of focal liver lesions 1
• Particularly important for hypervascular metastases (neuroendocrine, renal cell, melanoma, thyroid) 1
• Arterial phase timing: approximately 20 seconds after trigger threshold 2
• Portal venous phase: 50 seconds; delayed phase: 180 seconds 2

Hepatobiliary Contrast Agents

• Hepatobiliary MRI contrast agents allow both dynamic phases and delayed hepatobiliary phase imaging where lesions appear dark against bright liver parenchyma 1
• MRI with diffusion-weighted imaging combined with hepatobiliary phase provides greatest diagnostic accuracy 1

Critical Pitfalls to Avoid

Inadequate Contrast Technique

• Never rely on noncontrast CT for staging—sensitivity for metastases is severely limited 1
• Single-phase CT without proper timing misses significant disease burden 1
• Suboptimal contrast bolus timing reduces tumor-to-liver contrast and diagnostic accuracy 1

Insufficient Spatial Resolution

• Thick slices (>5 mm) increase partial volume averaging and miss small lesions 1
• Lack of multiplanar reformats reduces accuracy for assessing tumor relationships to critical structures 1

Incomplete Anatomic Coverage

• CT chest alone misses 14.5% of synchronous liver metastases in colorectal cancer 1
• Failure to include chest imaging misses pulmonary metastases, the second most common site after liver 1

Special Considerations

PET/CT Integration

• PET or PET-CT is recommended for lung cancer staging to detect unsuspected metastatic disease (Grade 1B) 1
• PET/CT sensitivity and specificity for mediastinal metastasis: approximately 77% and 86% respectively 1
• For lung cancer, contrast-enhanced CT as part of PET/CT protocol more accurately assessed TNM stage in 8% of patients compared to non-contrast PET/CT 3
• Tissue biopsy still required to confirm PET findings 1

Renal Insufficiency

• Iodinated CT contrast is potentially nephrotoxic in compromised renal function 1
• MRI without contrast may provide better soft-tissue detail than noncontrast CT when IV contrast contraindicated 1
• Gadolinium-based MRI contrast not nephrotoxic but carries black box warning for severe renal dysfunction (nephrogenic systemic fibrosis risk) 1

Radiation Dose Optimization

• Modern multidetector CT can cover 24 cm in 30 seconds with 1-1.25 mm sections 1
• Consider adaptive statistical iterative reconstruction to reduce radiation dose while maintaining image quality 4
• Low tube voltage (100 kVp) protocols with iterative reconstruction can decrease radiation dose by approximately 40% while maintaining diagnostic quality 4